Maven Securities LTD
Q2 2020 13F-HR Holdings
Net value change ($000)
+620,935
(73.8%)
New positions
154
Sold out positions
67
Turnover %
95.5%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q1 2020
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| BHP | 34,882 | NEW |
| QQQ | 22,059 | 3628.1% |
| AGIO | 16,044 | NEW |
| MyoKardia, Inc. | 14,493 | NEW |
| bluebird bio, Inc. | 12,208 | NEW |
| ALLO | 8,564 | NEW |
| PCG | 7,983 | NEW |
| IMMUNOMEDICS INC | 7,981 | NEW |
| WTW | 6,594 | NEW |
| ACI | 6,308 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| AAPL | -14,285 | -98.6% |
| Allergan plc | -12,233 | -100.0% |
| RYAAY | -8,135 | -100.0% |
| MSFT | -7,567 | -100.0% |
| AMZN | -6,338 | -94.1% |
| META | -5,731 | -100.0% |
| TOI | -5,704 | -68.1% |
| Wright Medical Group N.V. | -2,332 | -100.0% |
| TXN | -2,021 | -100.0% |
| SCHW | -1,663 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
1,088,313
(74.5% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|